ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1860

A Trial Testing Strategies to Enhance Patient Understanding of Drug Information:  Experience Recruiting Subjects through an Online Patient Community

Susan J. Blalock1, Elizabeth Solow2, W. Benjamin Nowell3, Steven Woloshin4, Lisa Schwartz4, Delesha M. Carpenter5, Jeffrey R. Curtis6, Larry W. Moreland7, Caprice Hunt1, Genevieve Hickey1 and Valerie Reyna8, 1Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Internal Medicine, Univesity of Texas Southwestern Medical Center, Dallas, TX, 3CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, 4Geisel School of Medicine, Dartmouth, Hanover, NH, 5Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Asheville, NC, 6Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 7Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Cornell University, Ithica, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Communication, Community programs, medication side effects and self-management

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: ARHP Education/Community Programs

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Current guidelines for the treatment of rheumatoid arthritis (RA) underscore the importance of an early and targeted approach to control inflammation. We describe initial experiences in recruiting RA patients (target n=300) from clinic sites versus an online patient support network into a randomized trial comparing the effectiveness of two educational interventions designed to enhance informed decision-making.

Methods: Participants are recruited from four clinic sites and CreakyJoints, an online patient support network. Eligibility criteria include: physician-diagnosed RA, moderate/high disease activity per the RAPID3, eligible for treatment escalation per provider, and internet access. Two interventions are being evaluated: (1) DrugFactsBoxes, which provide quantitative information concerning potential medication benefits and harms, and (2) Gist Reasoning Training, which is designed to help patients develop the skills needed to process complex information (e.g., the nature of scientific uncertainty). Data are collected by telephone interviews and on-line questionnaires. Because data collection is currently underway, this presentation focuses on the results of recruitment efforts.

Results: CreakyJoints sent 3,094 emails to their online community from January through March 2017, inviting members to participate in the study. Of these, 979 (31.6%) emaiIs were opened and 269 (8.6%) people clicked a link in the email taking them to the study website. A total of 156 (58.0%) of the CreakyJoints members who visited the website emailed study staff expressing interest in participating,139 met study eligibility criteria, and 96 have completed baseline data collection. During this same time period, 34 participants were recruited via the four clinic sites and completed baseline data collection. Compared to participants recruited via clinic sites, those recruited via CreakyJoints are less likely to be African-American (7% versus 22%, p = 0.02) or Hispanic (3% versus 14%, p = 0.02) and have greater RA knowledge (Means: 85.1 versus 75.4, p <0.0001) and higher health literacy as assessed by the Newest Vital Sign (Means: 83.5 versus 73.7, p = 0.02). Participants recruited via CreakyJoints, versus clinic sites, were equally likely to be women (95% versus 91%, p=0.46), have completed college (55% versus 61%, p=0.59), and be using a DMARD (12% versus 6%, p=0.28).

Conclusion: Recruitment from an online support community is feasible and efficient. Online participants may differ from clinic participants in some sociodemographic characteristics. Better understanding of these differences is needed to improve the generalizability of results generated from online communities and clinic sites to maximize the external validity of research findings.


Disclosure: S. J. Blalock, None; E. Solow, None; W. B. Nowell, Global Healthy Living Foundation, 3; S. Woloshin, None; L. Schwartz, None; D. M. Carpenter, None; J. R. Curtis, None; L. W. Moreland, None; C. Hunt, None; G. Hickey, None; V. Reyna, None.

To cite this abstract in AMA style:

Blalock SJ, Solow E, Nowell WB, Woloshin S, Schwartz L, Carpenter DM, Curtis JR, Moreland LW, Hunt C, Hickey G, Reyna V. A Trial Testing Strategies to Enhance Patient Understanding of Drug Information:  Experience Recruiting Subjects through an Online Patient Community [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-trial-testing-strategies-to-enhance-patient-understanding-of-drug-information-experience-recruiting-subjects-through-an-online-patient-community/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-trial-testing-strategies-to-enhance-patient-understanding-of-drug-information-experience-recruiting-subjects-through-an-online-patient-community/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology